AbbVie (ABBV) Dividend Coverage Ratio (QoQ) (2013 - 2026)
Powered by 
Analysis
AbbVie (ABBV) Dividend Coverage Ratio (QoQ) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.10 Bn | 625.34 Bn | 17.26 Bn |
| 2 | AbbVie | 441.68 Bn | 435.11 Bn | 12.70 Bn |
| 3 | Merck | 366.62 Bn | 359.48 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.55 Bn | 258.86 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - |
| 8 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 421.50% |
| Mar 31, 2026 | -63.78% |
| Dec 31, 2025 | 865.43% |
| Sep 30, 2025 | -80.03% |
| Jun 30, 2025 | -26.62% |
| Mar 31, 2025 | 5,372.88% |
| Dec 31, 2024 | -101.47% |
| Sep 30, 2024 | 13.87% |
| Jun 30, 2024 | 0.87% |
| Mar 31, 2024 | 57.74% |
| Dec 31, 2023 | -53.72% |
| Sep 30, 2023 | -12.20% |
| Jun 30, 2023 | 2,218.35% |
| Mar 31, 2023 | -103.70% |
| Dec 31, 2022 | -37.50% |
| Sep 30, 2022 | 326.37% |
| Jun 30, 2022 | -79.19% |
| Mar 31, 2022 | 1.75% |
| Dec 31, 2021 | 27.26% |
| Sep 30, 2021 | 312.63% |